News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,761 Results
Type
Article (40164)
Company Profile (271)
Press Release (662326)
Multimedia
Podcasts (55)
Webinars (12)
Section
Business (205115)
Career Advice (2021)
Deals (35538)
Drug Delivery (97)
Drug Development (81275)
Employer Resources (172)
FDA (16244)
Job Trends (14921)
News (346546)
Policy (32674)
Tag
Academia (2572)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (49790)
ALS (94)
Alzheimer's disease (1390)
Antibody-drug conjugate (ADC) (136)
Approvals (16238)
Artificial intelligence (262)
Autoimmune disease (23)
Automation (16)
Bankruptcy (363)
Best Places to Work (11659)
BIOSECURE Act (20)
Biosimilars (107)
Biotechnology (190)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (292)
Cancer (2318)
Cardiovascular disease (179)
Career advice (1689)
Career pathing (30)
CAR-T (158)
Cell therapy (441)
Cervical cancer (20)
Clinical research (66209)
Collaboration (863)
Company closure (2)
Compensation (564)
Complete response letters (19)
COVID-19 (2609)
CRISPR (43)
C-suite (252)
Cystic fibrosis (101)
Data (2305)
Decentralized trials (2)
Denatured (21)
Depression (45)
Diabetes (277)
Diagnostics (6400)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (105)
Drug shortages (26)
Duchenne muscular dystrophy (96)
Earnings (87115)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (113132)
Executive appointments (744)
FDA (17608)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (771)
Gene editing (112)
Generative AI (19)
Gene therapy (313)
GLP-1 (725)
Government (4450)
Grass and pollen (4)
Guidances (151)
Healthcare (18840)
Huntington's disease (25)
IgA nephropathy (27)
Immunology and inflammation (125)
Indications (29)
Infectious disease (2756)
Inflammatory bowel disease (147)
Inflation Reduction Act (11)
Influenza (54)
Intellectual property (97)
Interviews (312)
IPO (16555)
IRA (42)
Job creations (3668)
Job search strategy (1434)
Kidney cancer (10)
Labor market (43)
Layoffs (482)
Leadership (17)
Legal (7945)
Liver cancer (77)
Lung cancer (324)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (325)
MASH (75)
Medical device (13394)
Medtech (13399)
Mergers & acquisitions (19551)
Metabolic disorders (710)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (94)
Neuropsychiatric disorders (27)
Neuroscience (1943)
NextGen: Class of 2025 (6549)
Non-profit (4491)
Now hiring (40)
Obesity (374)
Opinion (210)
Ovarian cancer (80)
Pain (93)
Pancreatic cancer (89)
Parkinson's disease (150)
Partnered (21)
Patents (241)
Patient recruitment (115)
Peanut (46)
People (57671)
Pharmaceutical (67)
Pharmacy benefit managers (19)
Phase I (20641)
Phase II (29172)
Phase III (21709)
Pipeline (1348)
Policy (150)
Postmarket research (2564)
Preclinical (8791)
Press Release (64)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (383)
Real estate (5953)
Recruiting (65)
Regulatory (22411)
Reports (47)
Research institute (2327)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (135)
Series B (88)
Service/supplier (13)
Sickle cell disease (53)
Special edition (17)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3633)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (48)
The Weekly (32)
Vaccines (702)
Venture capitalists (44)
Weight loss (240)
Women's health (36)
Worklife (16)
Date
Today (29)
Last 7 days (938)
Last 30 days (2978)
Last 365 days (32492)
2025 (11748)
2024 (35338)
2023 (40186)
2022 (51293)
2021 (55841)
2020 (54159)
2019 (46645)
2018 (35124)
2017 (32224)
2016 (31631)
2015 (37709)
2014 (31455)
2013 (26501)
2012 (28770)
2011 (29427)
2010 (27525)
Location
Africa (721)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38093)
Australia (6240)
California (6401)
Canada (2061)
China (536)
Colorado (273)
Connecticut (278)
Delaware (156)
Europe (81899)
Florida (947)
Georgia (212)
Idaho (58)
Illinois (548)
India (26)
Indiana (320)
Iowa (11)
Japan (171)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (919)
Massachusetts (4746)
Michigan (223)
Minnesota (401)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (64)
New Jersey (1786)
New Mexico (28)
New York (1797)
North Carolina (986)
North Dakota (8)
Northern California (2816)
Ohio (210)
Oklahoma (14)
Oregon (35)
Pennsylvania (1420)
Puerto Rico (13)
Rhode Island (33)
South America (1100)
South Carolina (25)
South Dakota (1)
Southern California (2411)
Tennessee (105)
Texas (950)
United States (23945)
Utah (188)
Virginia (152)
Washington D.C. (65)
Washington State (566)
West Virginia (3)
Wisconsin (56)
702,761 Results for "greenlight biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
2024 Ends With Greenlights for Merck’s PAH Drug in UK and BMS’ Opdivo Injection in US
Regulators squeezed in two final approvals before the calendar change with the UK approval of Merck’s Winrevair and the FDA’s greenlight for an injectable formulation of BMS’s cancer blockbuster.
January 2, 2025
·
2 min read
·
Kate Goodwin
Genetown
GreenLight Biosciences Secures EPA Registration for New Bioinsecticide, Calantha, Historic Step Towards A Safer and More Sustainable Food System
GreenLight Biosciences (GreenLight Bio) has been granted registration by the U.S. Environmental Protection Agency (EPA) and several states for its groundbreaking Calantha™ product, designed to target and control the highly destructive Colorado potato beetle.
January 4, 2024
·
5 min read
Deals
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that it is initiating the final steps in closing its previously announced merger with SW MergerCo, Inc. (“Merger Sub”) and SW ParentCo, Inc (“Parent”).
July 20, 2023
·
6 min read
Deals
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
GreenLight Biosciences Holdings, PBC announced the closing of its previously announced merger with SW MergerCo, Inc. and SW ParentCo, Inc., pursuant to which Merger Sub merged with and into GreenLight with GreenLight surviving as a wholly-owned subsidiary of Parent.
July 24, 2023
·
5 min read
Press Releases
Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook
May 8, 2025
·
16 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
Press Releases
Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025
May 8, 2025
·
6 min read
Press Releases
IDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
May 6, 2025
·
14 min read
Press Releases
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
April 23, 2025
·
4 min read
Press Releases
Xenetic Biosciences, Inc. Releases Virtual Investor “What This Means” Segment
April 10, 2025
·
5 min read
1 of 70,277
Next
